Proinflammatory pathways are upregulated in KRAS-dependent tumors, including increased production of the chemokines IL-1β, CCL7, and CCL2, as a result of crosstalk between KRAS-mutant tumor cells and host myeloid cells54. This evidence concerns the gene CCL7 and neoplasm.